CVS Health Corporation (ETR:CVS)
Germany · Delayed Price · Currency is EUR | Market Cap | 68.62B |
| Revenue (ttm) | 327.26B |
| Net Income (ttm) | 3.86B |
| Shares Out | n/a |
| EPS (ttm) | 3.06 |
| PE Ratio | 17.79 |
| Forward PE | 9.53 |
| Dividend | 2.40 (4.48%) |
| Ex-Dividend Date | Jul 22, 2025 |
| Volume | 1,684 |
| Average Volume | 1,134 |
| Open | 54.15 |
| Previous Close | 53.48 |
| Day's Range | 53.41 - 54.63 |
| 52-Week Range | 41.68 - 65.16 |
| Beta | n/a |
| RSI | 44.72 |
| Earnings Date | Jul 31, 2025 |
About Aerovate Therapeutics
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs and Medicaid health care management services. It serves employer groups, individuals, coll... [Read more]
Financial Performance
In 2024, CVS Health's revenue was $370.66 billion, an increase of 3.93% compared to the previous year's $356.62 billion. Earnings were $4.61 billion, a decrease of -44.70%.
Financial StatementsNews
Walmart, CVS, Panera and more quietly close more stores
‘The world is on edge’: five tumultuous weeks with David Lammy, foreign secretary at a time of crisis
His first 12 months at the Foreign Office have been hit by a string of high-stakes international flashpoints, from the unfolding horror in Gaza to regime change in Syria and Trump’s humiliation of Zel...
5 Dividend Stocks With Solid Returns And More Growth Ahead
Sector by sector, U.S. dividend stocks have outperformed so far this year, with historically dividend-friendly industries surpassing those with a more growth-oriented focus.
CVS Targets Strong Weight-Loss Drug Use as Revenues Tick Up
CVS is focusing heavily on technology-led care after posting solid Q2 earnings. “We are building momentum as we navigate what continues to be a dynamic and evolving environment,” Chief Executive David...
CVS Health Will Invest $20 Billion To Simplify US Health System, Delivers Strong Q2 Despite Legal Setbacks
CVS Health Corp (NYSE: CVS) stock is trading higher on Thursday after the company reported better-than-expected Q2 earnings and raised its annual guidance. The company reported second-quarter sales o...
CVS Health Will Invest $20 Billion To Simplify US Health System, Delivers Strong Q2 Despite Legal Setbacks
CVS Health Corp CVS stock is trading higher on Thursday after the company reported better-than-expected Q2 earnings and raised its annual guidance.
CVS Health Stock Surges After Earnings Smash Forecasts. A Value Play Has Become a Rally.
Cramer's Mad Dash: CVS Health
Jim Cramer breaks down why he's keeping an eye on CVS Health.
Cramer's Mad Dash: CVS Health
Jim Cramer breaks down why he's keeping an eye on CVS Health.
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-2226653005-a5ccf9a5326942ba8d0f42fe2cf3d91c.jpg)
CVS Health Stock Soars on Strong Results, Raised 2025 Profit Outlook
Shares of CVS Health jumped in premarket trading Thursday after the health care giant posted better-than-expected second-quarter results and lifted its full-year adjusted profit forecast.
Stocks making the biggest premarket moves: CVS, Comcast, Meta, Norwegian Cruise and more
These are the stocks posting the largest moves in the premarket.
CVS stock jumps over 8% as turnaround fuels earnings beat, outlook raised
Shares of CVS Health jumped in premarket trading Thursday after the healthcare and pharmacy giant reported better-than-expected second-quarter earnings and lifted its full-year forecast, marking its t...
CVS Health gains after Q2 beat despite rising medical costs
CVS beats estimates - hikes adjusted profit outlook on retail pharmacy and insurance unit strength
CNBC's Bertha Coombs joins 'Squawk Box' to break down the company's quarterly earnings results.
CVS Profits Eclipse $1 Billion As Aetna's Costs Begin To Stabilize
CVS Health Thursday reported $1 billion in second quarter net income as the company begins to get a handle on the health benefit costs that have dogged its Aetna health insurance business as well as i...
CVS’s stock jumps, as profit beats by a wide margin and the outlook is raised
CVS Health in Charts: Double-digit Y/Y growth seen across all segments in Q2
CVS beats estimates, hikes adjusted profit outlook on retail pharmacy and insurance unit strength
CNBC's Bertha Coombs joins 'Squawk Box' to break down the company's quarterly earnings results.
CVS second-quarter profit beats estimates, helped by medical cost oversight
CVS Health beat Wall Street estimates for second-quarter profit on Thursday, as tight oversight of higher medical costs led to improved performance for its Aetna health insurance business.
CVS beats estimates, hikes adjusted profit outlook on retail pharmacy and insurance unit strength
CVS Health reported second-quarter earnings and revenue that topped estimates and raised its adjusted profit outlook. CVS CEO David Joyner pointed to strength in its retail pharmacy business and some ...
CVS Non-GAAP EPS of $1.81 beats by $0.35, revenue of $98.92B beats by $4.33B
CVS Shows Signs of Recovery, Beats Wall Street Expectations
CVS HEALTH CORPORATION REPORTS SECOND QUARTER 2025 RESULTS AND UPDATES FULL-YEAR 2025 GUIDANCE
Financial Highlights Second quarter total revenues increased to $98.9 billion, up 8.4% compared to prior year Second quarter GAAP diluted EPS of $0.80 and Adjusted EPS of $1.81 Generated year-to-date ...
Top Wall Street Forecasters Revamp CVS Health Expectations Ahead Of Q2 Earnings
CVS Health Corporation (NYSE: CVS) will release earnings results for the second quarter before the opening bell on Thursday, July 31. Analysts expect the Woonsocket, Rhode Island-based company to rep...